登录新浪财经APP 搜索【信披】查看更多考评等级辰欣药业8月30日发布关于持股5%以上股东减持股份计划公告，披露了持股5%以上股东石家庄四药有限公司（以下简称“石四药”）的减持计划。减持主体基本情况减持主体为石四药，并非控股股东、实控人及一致行动人，作为直接持股5%以上股东，截至公告披露时，持有辰欣药业无限售流通股份27,661,441股，占辰欣药业总股本的6.11%，股份来源为协议转让取得。且该...
Source Link登录新浪财经APP 搜索【信披】查看更多考评等级辰欣药业8月30日发布关于持股5%以上股东减持股份计划公告，披露了持股5%以上股东石家庄四药有限公司（以下简称“石四药”）的减持计划。减持主体基本情况减持主体为石四药，并非控股股东、实控人及一致行动人，作为直接持股5%以上股东，截至公告披露时，持有辰欣药业无限售流通股份27,661,441股，占辰欣药业总股本的6.11%，股份来源为协议转让取得。且该...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.